JP2009534667A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534667A5
JP2009534667A5 JP2009506738A JP2009506738A JP2009534667A5 JP 2009534667 A5 JP2009534667 A5 JP 2009534667A5 JP 2009506738 A JP2009506738 A JP 2009506738A JP 2009506738 A JP2009506738 A JP 2009506738A JP 2009534667 A5 JP2009534667 A5 JP 2009534667A5
Authority
JP
Japan
Prior art keywords
protein
cancer cells
immunoassay
blood
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009506738A
Other languages
English (en)
Japanese (ja)
Other versions
JP5025724B2 (ja
JP2009534667A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/066857 external-priority patent/WO2007121465A2/en
Publication of JP2009534667A publication Critical patent/JP2009534667A/ja
Publication of JP2009534667A5 publication Critical patent/JP2009534667A5/ja
Application granted granted Critical
Publication of JP5025724B2 publication Critical patent/JP5025724B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009506738A 2006-04-18 2007-04-18 循環腫瘍性細胞からのタンパク質の検出 Expired - Fee Related JP5025724B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74501606P 2006-04-18 2006-04-18
US60/745,016 2006-04-18
PCT/US2007/066857 WO2007121465A2 (en) 2006-04-18 2007-04-18 Detection of proteins from circulating neoplastic cells

Publications (3)

Publication Number Publication Date
JP2009534667A JP2009534667A (ja) 2009-09-24
JP2009534667A5 true JP2009534667A5 (enExample) 2010-04-30
JP5025724B2 JP5025724B2 (ja) 2012-09-12

Family

ID=38610457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009506738A Expired - Fee Related JP5025724B2 (ja) 2006-04-18 2007-04-18 循環腫瘍性細胞からのタンパク質の検出

Country Status (6)

Country Link
US (1) US8012480B2 (enExample)
EP (1) EP2008102A4 (enExample)
JP (1) JP5025724B2 (enExample)
CA (1) CA2647843A1 (enExample)
MX (1) MX2008013332A (enExample)
WO (1) WO2007121465A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4798801B2 (ja) * 2004-10-06 2011-10-19 ウェルスタット バイオロジクス コーポレイション 循環する癌細胞におけるＨｅｒ−２／ｎｅｕタンパク質のレベルの上昇の検出および処置
EP2145188A4 (en) * 2007-04-19 2010-06-30 Wellstat Biologics Corp DETECTION OF HER2 / NEU PROTEIN FROM UNISISIONED CIRCULATING CANCER CELLS AND TREATMENT
US11072655B2 (en) 2008-01-15 2021-07-27 The Board Of Trustees Of The Leland Stanford Junior University Markers of acute myeloid leukemia stem cells
CA2711370C (en) 2008-01-15 2017-06-13 The Board Of Trustees Of The Leland Stanford Junior University Markers of acute myeloid leukemia stem cells
PT3056515T (pt) 2008-01-15 2019-07-19 Univ Leland Stanford Junior Métodos para manipulação da fagocitose mediada por cd47
WO2011162904A2 (en) * 2010-05-24 2011-12-29 Marek Malecki Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use priority statement
WO2012051390A1 (en) * 2010-10-14 2012-04-19 Veridex, Llc Methods and kits for the detection of circulating tumor cells in pancreatic patients using polyspecific capture and cocktail detection reagents
CN102680456B (zh) 2011-03-16 2015-07-08 北京联众泰克科技有限公司 一种电化学发光免疫测定方法
CN107315086B (zh) 2011-06-29 2019-09-10 中央研究院 使用表面涂层对生物物质的捕获、纯化和释放
WO2013036620A1 (en) * 2011-09-06 2013-03-14 Becton, Dickinson And Company Methods and compositions for cytometric detection of rare target cells in a sample
WO2014147631A1 (en) 2013-03-22 2014-09-25 Natco Pharma Limited Formulation comprising gefitinib as oral suspension
TW201623605A (zh) 2014-04-01 2016-07-01 中央研究院 用於癌症診斷及預後之方法及系統
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
EP3194616B1 (en) * 2014-09-18 2020-07-29 AdnaGen GmbH Mrna and/or protein of ercc1 isoform 3 for use in diagnosing a resistance against a therapeutic agent and method for diagnosing a resistance against a therapeutic agent using said mrna and/or protein
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
CN109991410B (zh) * 2017-12-29 2022-07-05 上海白泽医学检验所有限公司 一种含抗cd45单抗的组合物及其使用方法
CN114487059B (zh) * 2021-12-29 2022-11-25 苏州大学 一种电化学发光免疫传感器及其制备和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494135B1 (en) * 1989-09-29 1996-04-10 Oncogene Science, Inc. Human "neu" related protein p100 and use of the same for detecting preneoplastic or neoplastic cells in a human
ES2285713T3 (es) * 1995-06-07 2007-11-16 Bioveris Corporation Enzimoinmunoanalisis electroquimioluminiscente.
US6960449B2 (en) * 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
US7537938B2 (en) 2000-04-28 2009-05-26 Monogram Biosciences, Inc. Biomarker detection in circulating cells
BR0207290A (pt) * 2001-02-16 2005-06-07 Immunivest Corp Método para analisar um paciente quanto à presença de uma malignidade, célula maligna isolada das células cultivadas, vacina de tumor, molécula associada com diátese de tumor alterada, métodos para determinar alterações em moléculas associadas com diátese de tumor como um meio para predizer a eficácia da terapia, como um meio para analisar dosagem apropriada para terapia, como um meio para monitorar eficácia da terapia, como um meio para analisar progressão de câncer, para realizar uma biópsia de corpo inteiro em um paciente, e para identificar alterações em uma célula de tumor circulante relativamente a células presentes numa massa de tumor in situ, e, kit de teste para analisar uma amostra de paciente quanto à presença de uma célula maligna não-hematopoiética
IL161357A0 (en) * 2001-10-26 2004-09-27 Immunivest Corp Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
EP1516186B1 (en) * 2002-06-26 2010-02-17 University Of Louisville Research Foundation, Inc. A method for the detection of apoptosis
HUP0600340A3 (en) 2002-07-15 2011-06-28 Genentech Inc Methods for identifying tumors that are responsive to treatment with anti-erbb2 antibodies
BRPI0408928A (pt) * 2003-04-01 2006-09-12 Monogram Biosciences Inc métodos para determinar uma situação de doença em um paciente, uma situação apoptótica de células em uma amostra, e uma situação de um cáncer em um paciente
JP2007502983A (ja) * 2003-08-15 2007-02-15 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション がん検出のための多因子アッセイ
JP5422120B2 (ja) * 2004-05-27 2014-02-19 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイト 癌患者による上皮成長因子受容体阻害薬に対する臨床転帰の予測方法
JP2008523784A (ja) * 2004-09-14 2008-07-10 ジョン ウェイン キャンサー インスティチュート 体液中癌細胞の検出
JP4798801B2 (ja) 2004-10-06 2011-10-19 ウェルスタット バイオロジクス コーポレイション 循環する癌細胞におけるＨｅｒ−２／ｎｅｕタンパク質のレベルの上昇の検出および処置

Similar Documents

Publication Publication Date Title
WO2007121465B1 (en) Detection of proteins from circulating neoplastic cells
CN102304581B (zh) 用于检测kras基因突变的试剂盒及其检测方法
Wang et al. CRISPR/Cas9 bridged recombinase polymerase amplification with lateral flow biosensor removing potential primer-dimer interference for robust Staphylococcus aureus assay
Lopez-Nunez et al. New molecular insights into the pathogenesis of lipoblastomas: clinicopathologic, immunohistochemical, and molecular analysis in pediatric cases
MX2012008153A (es) Metodos para predecir la respuesta a terapia de cancer de mama triple negativo.
Xu et al. Colorimetric assay of rare disseminated tumor cells in real sample by aptamer-induced rolling circle amplification on cell surface
JP2011513728A5 (enExample)
US20110159561A1 (en) Kit and method for the capture of tumor cells
WO2009128960A3 (en) Rapid test including genetic sequence probe
Tak et al. High-content quantum dot-based subtype diagnosis and classification of breast cancer patients using hypermulticolor quantitative single cell imaging cytometry
KR102211972B1 (ko) 액체생검 다중 암 유전자 바이오마커를 이용한 유방암 조기진단 및 치료 후 모니터링 방법
CN114958953A (zh) 一种化妆品原料体外3d全皮皮肤模型抗衰老功效的筛选方法
RU2012148816A (ru) Метод диагностики для определения клеток ex vivo
Fusco et al. Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
Huang et al. Simultaneous determination of three potential cancer biomarkers in rat urine by synchronous fluorescence spectroscopy
CN103430890B (zh) 一种斑马鱼体内ros检测模型的建立方法及其应用
CN103882138A (zh) 一种与抗肿瘤用药相关的多重基因检测试剂盒
Zheng et al. Rapid identification of medicinal leech by species-specific polymerase chain reaction technology
Zhao et al. Study on the precise mechanism of Mitoxantrone-induced Jurkat cell apoptosis using surface enhanced Raman scattering
CN102181536A (zh) 用于检测人类egfr基因19号外显子突变的引物组合物、试剂盒及方法
CN111272894A (zh) 一种地龙1h nmr指纹图谱的构建方法与应用
WO2006089219A3 (en) Neoepitope detection of disease using protein arrays
CN108384857A (zh) ddPCR技术检测IDH1 R132H基因变异的引物、试剂盒及检测方法
CN103958694B (zh) 谷草转氨酶和乳酸脱氢酶的检测在早期评估抗肿瘤干预措施临床疗效中的应用
CN105838780A (zh) ddPCR技术监控黑色素瘤患者对维罗非尼耐药的方法